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This brief communication discusses a much neglected topic in functional 
neuroanatomy—the possible function(s) of the adrenergic system in the brain.  
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There are four aminergic neuromodulatory systems in the brain: these use 
dopamine, norepinephrine, serotonin and adrenaline1. There is a vast literature 
about the first three, but very little work has been done on the fourth, that has 
achieved a Cinderella status amongst the brain’s neuromodulators. It is certainly 
a phylogenetically very primitive system, since its C1-C3 cell bodies are located 
in a more primitive location—the medulla—than the others, which have their cell 
bodies higher up in the pons, midbrain and basal forebrain. It has merely been 
assumed, without much evidence, that it may be restricted to low-level functions, 
such as cardiac and respiratory control. However, its neuroanatomical 
connections suggest something more interesting in addition. These nuclei have 
extensive rostral projections that reach as far up as the thalamus, and, more 
particularly from our present point of view, to the nuclei of all the other 
neuromodulators—substantia nigra (dopamine)2; the locus coeruleus (NE)3; the 
raphe nucleus (5-HT)4; and the lateral dorsal tegmental nucleus (cholinergic)5; 
as well as to key limbic structures, such as the hypothalamus6; the central 


































of the thalamus9. It is difficult to see why a system, that is supposed to control 
only low-level functions, such as heart rate and blood pressure, would need this 
extensive projection to many of the key higher areas of the limbic system that is 
concerned inter alia with emotion. 
The neuromodulatory system in the brain is not only exceedingly 
complicated but is also densely anatomically and physiologically interlinked, so 
that a primary disturbance in one system soon affects several other systems. 
However, it is not the purpose of this paper to review this extensive literature, but 
to spotlight one previously neglected area. The most basic behaviour exhibited 
by unicellular organisms is attraction (to food and safety) and repulsion (from 
danger). As organisms get more complex and develop nervous systems, this 
basic approach/flee dichotomy becomes elaborated and mediated by specific 
neurochemical mechanisms. In higher brains, behaviours of this kind are 
mediated anatomically by the limbic system, and neurochemically by the 
neuromodulator system.  
 Under normal circumstances this attract/repel—approach/flee mechanism 
fluctuates on either side of a neutral norm. Approach behaviour is associated 
with positive emotions and positive cognition, particularly when reinforced by 
consumatory input. Retreat behaviour is associated with negative emotions 
(particularly fear), especially is associated with the advent of painful stimuli. The 
control of approach/escape behaviours is mediated by extremely complex 
interactions between the neurotransmitters dopamine, norepinephrine, serotonin 


































ideation are all integrated into a prevailing mood. This integration could be 
effected by mutual interactions between the main neuromodulatory systems. Or 
there could be a master control —the conductor of this orchestra so to speak. 
The adrenergic system is well placed and well connected to act as the putative 
conductor of this orchestra, just as the cholinergic pedunculopontine and lateral 
dorsal tegmental nuclei in the pons and midbrain orchestrate consciousness in 
the brain10, so the even more fundamental C1-C3 adrenergic nuclei in the 
medulla could orchestrate the basic behaviours of approach and retreat, with all 
their emotional and cognitive accompaniments. Disorders of this system could 
play a role in mood disturbances such as bipolar disorder. Further research on 
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